FDA advisory committee still discussing booster shots
The S&P 500 continues to trade near session lows with a 0.9% decline just below its 50-day moving average (4437). The FDA advisory committee should come out with a decision on booster shots this afternoon. An Evercore ISI analyst told CNBC earlier that he doesn't think the FDA will authorize the COVID-19 booster shots today, though. Part of his reasoning was that the FDA is focused on severe disease and hospitalization, and the effectiveness of current vaccines still protect against that. Looking ahead, Lennar (LEN 100.50, +0.25, +0.3%) will report earnings on Monday.